GROWTH OF TESTICULAR NEOPLASM LUNG METASTASES: TUMOR-SPECIFIC RELATION BETWEEN TWO GOMPERTZIAN PARAMETERSDEMICHELI R.1980; EUR. J. CANCER; ISSN 0014-2964; GBR; DA. 1980; VOL. 16; NO 12; PP. 1603-1608; BIBL. 7 REF.Article

A NEW CMF REGIMENDEMICHELI R; FOSSATI V; GARUSI GF et al.1980; TUMORI; ISSN 0300-8916; ITA; DA. 1980; VOL. 66; NO 6; PP. 743-748; ABS. ITA; BIBL. 7 REF.Article

Gene regulatory networks: a new conceptual framework to analyse breast cancer behaviourDEMICHELI, R; CORADINI, D.Annals of oncology. 2011, Vol 22, Num 6, pp 1259-1265, issn 0923-7534, 7 p.Article

PROSPECTIVE STUDY WITH HEXA-CAF COMBINATION IN OVARIAN CARCINOMADE PALO G; DEMICHELI R; VALAGUSSA P et al.1981; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1981; VOL. 5; NO 3; PP. 157-161; BIBL. 21 REF.Article

Analysis of free growth and post-treatment regrowth of C3H mammary carcinoma in individual miceDEMICHELI, R; FORONI, R; GIULIANI, F et al.Cell and tissue kinetics. 1986, Vol 72, Num 73, pp 471-476, issn 0008-8730Article

Double-peaked time distribution of mortality for breast cancer patients undergoing mastectomyDEMICHELI, R; VALAGUSSA, P; BONADONNA, G et al.Breast cancer research and treatment. 2002, Vol 75, Num 2, pp 127-134, issn 0167-6806, 8 p.Article

Estimate of tumor growth time for breast cancer local recurrences : rapid growth after wake-up?DEMICHELI, R; TERENZIANI, M; BONADONNA, G et al.Breast cancer research and treatment. 1998, Vol 51, Num 2, pp 133-137, issn 0167-6806Article

Does surgery modify growth kinetics of breast cancer micrometastases?DEMICHELI, R; VALAGUSSA, P; BONADONNA, G et al.British journal of cancer. 2001, Vol 85, Num 4, pp 490-492, issn 0007-0920Article

Premenopausal status accelerates relapse in node positive breast cancer : hypothesis links angiogenesis, screening controversyRETSKY, M; DEMICHELI, R; HRUSHESKY, W et al.Breast cancer research and treatment. 2001, Vol 65, Num 3, pp 217-224, issn 0167-6806Article

Proposal for a new model of breast cancer metastatic developmentDEMICHELI, R; RETSKY, M. W; SWARTZENDRUBER, D. E et al.Annals of oncology. 1997, Vol 8, Num 11, pp 1075-1080, issn 0923-7534Article

Time distribution of the recurrence risk for breast cancer patients under going mastectomy : further support about the oncept of tumor dormancyDEMICHELI, R; ABBATTISTA, A; MICELI, R et al.Breast cancer research and treatment. 1996, Vol 41, Num 2, pp 177-185, issn 0167-6806Article

Etat de mal syncopal au cours d'une névralgie du glossopharyngien = Syncopal status in a case of glossopharyngeal nevralgiaMESSIN, R; SCHEFFMAN, M; COQUILLAT, G et al.Annales médicales de Nancy et de l'Est. 1986, Vol 25, Num 1, pp 29-30, issn 0221-3796Article

Local recurrences following mastectomy : support for the concept of tumor dormancyDEMICHELI, R; TERENZIANI, M; VALAGUSSA, P et al.Journal of the National Cancer Institute. 1994, Vol 86, Num 1, pp 45-48, issn 0027-8874Article

Factors causing dose variability in drug administrationDEMICHELI, R; JIRILLO, A; BONCIARELLI, G et al.Cancer chemotherapy and pharmacology. 1989, Vol 24, Num 6, pp 363-366, issn 0344-5704Article

The effects of surgery on tumor growth : a century of investigationsDEMICHELI, R; RETSKY, M. W; HRUSHESKY, W. J. M et al.Annals of oncology. 2008, Vol 19, Num 11, pp 1821-1828, issn 0923-7534, 8 p.Article

Five-day infusion fluorouracil plus vinorelbine in women with breast cancer previously treated with anthracyclines and paclitaxelZAMBETTI, M; MARIANI, G; DEMICHELI, R et al.Breast cancer research and treatment. 2000, Vol 62, Num 2, pp 135-139, issn 0167-6806Article

An exponential-Gompertzian description of LoVo cell tumor growth from in vivo and in vitro dataDEMICHELI, R; FORONI, R; INGROSSO, A et al.Cancer research (Baltimore). 1989, Vol 49, Num 23, pp 6543-6546, issn 0008-5472Article

Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF). Data supporting the occurrence of 'cures'DEMICHELI, R; MICELI, R; BRAMBILLA, C et al.Breast cancer research and treatment. 1999, Vol 53, Num 3, pp 209-215, issn 0167-6806Article

Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancerMARIANI, G; TAGLIABUE, P; ZUCCHINELLI, P et al.Breast cancer research and treatment. 2001, Vol 70, Num 3, pp 163-169, issn 0167-6806Article

Drugs ten years later: epirubicinBONADONNA, G; GIANNI, L; SANTORO, A et al.Annals of oncology. 1993, Vol 4, Num 5, pp 359-369, issn 0923-7534Article

Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic processDEMICHELI, R; MICELI, R; MOLITERNI, A et al.Annals of oncology. 2005, Vol 16, Num 9, pp 1449-1457, issn 0923-7534, 9 p.Article

Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancerRETSKY, M. W; DEMICHELI, R; HRUSHESKY, W. J. M et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2008, Vol 116, Num 7-8, pp 730-741, issn 0903-4641, 12 p.Article

Vinorelbine : an active, non cross-resistant drug in advanced breast cancer. Results from a phase II studyTERENZIANI, M; DEMICHELI, R; BRAMBILLA, C et al.Breast cancer research and treatment. 1996, Vol 39, Num 3, pp 285-291, issn 0167-6806Article

Five-day infusion fluorouracil plus vinorelbine i.v. in metastatic pretreated breast cancer patientsZAMBETTI, M; DEMICHELI, R; DE CANDIS, D et al.Breast cancer research and treatment. 1997, Vol 44, Num 3, pp 255-260, issn 0167-6806Article

Cisplatin, doxorubicin and cyclophosphamide in advanced salivary and carcinoma : A phase II trial of 22 patientsLICITRA, L; CAVINA, R; GRANDI, C et al.Annals of oncology. 1996, Vol 7, Num 6, pp 640-642, issn 0923-7534Article